RALLYBIO CORPORATION Deferred Tax Assets, Operating Loss Carryforwards, Domestic
RALLYBIO CORPORATION (RLYB) had Deferred Tax Assets, Operating Loss Carryforwards, Domestic of $183.30 million as of 2025-12-31, per its S-4/A filed 2026-08-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Operating Loss Carryforwards, Components
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic · last filed 2026-08-26
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $183.30M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $167.40M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $135.10M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $98.90M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Domestic |
|---|---|
| 2025-12-31 | $183.30M S-4/A · filed 2026-08-26 |
| 2024-12-31 | $167.40M 10-K · filed 2025-03-13 |
| 2023-12-31 | $135.10M 10-K · filed 2024-03-12 |
| 2022-12-31 | $98.90M 10-K · filed 2023-03-06 |
| 2021-12-31 | $83.10M 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |